The antibody radionuclide conjugates market is growing as oncology research moves toward more targeted treatment approaches. These therapies combine the targeting ability of antibodies with radioactive isotopes, creating a potential way to deliver radiation more directly to selected cancer cells.
The Antibody Radionuclide Conjugates Market includes monoclonal antibodies, polyclonal antibodies,...
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek